Columbia Research Enhanced Value ETF
REVS
19 hedge funds and large institutions have $64.9M invested in Columbia Research Enhanced Value ETF in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
16% more capital invested
Capital invested by funds: $55.7M → $64.9M (+$9.17M)
12% more funds holding
Funds holding: 17 → 19 (+2)
0.16% more ownership
Funds ownership: 84.91% → 85.07% (+0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
+$3.96M |
| 2 |
LPL Financial
San Diego,
California
|
+$2.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$491K |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$360K |
| 5 |
EFS
Essex Financial Services
Essex,
Connecticut
|
+$201K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$665K |
| 2 |
GS
GWN Securities
Palm Beach Gardens,
Florida
|
-$553K |
| 3 |
Jane Street
New York
|
-$237K |
| 4 |
FFC
Frederick Financial Consultants
Frederick,
Maryland
|
-$63.5K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$37.4K |
REVS Hedge Fund Activity: Q2 2025 in Review
19 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q2 2025, worth a combined $64.9M — up 16% from $55.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new REVS positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was Raymond James Financial, adding an estimated $3.96M. The largest seller was Cambridge Investment Research Advisors, cutting an estimated $665K.
- 19 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q2 2025, up from 17 in Q1 2025.
- Funds reported $64.9M of Columbia Research Enhanced Value ETF stock for Q2 2025, up 16% quarter-over-quarter.
- 4 funds opened new Columbia Research Enhanced Value ETF positions in Q2 2025 and 2 closed out, a net change of +2 holders.
- The largest Columbia Research Enhanced Value ETF buyer in Q2 2025 was Raymond James Financial, an estimated $3.96M added.
- The largest Columbia Research Enhanced Value ETF seller in Q2 2025 was Cambridge Investment Research Advisors, an estimated $665K sold.
Based on aggregated 13F filings for Q2 2025.